RecruitingNot applicableNCT06455163

Eerder Erbij: The Path Towards Offering Timely Support for People With Dementia and Their Caregivers

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
VU University of Amsterdam
Intervention
Eerder Erbij(other)
Enrollment
102 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2026

Study locations (1)

Collaborators

ZonMw: The Netherlands Organisation for Health Research and Development · Maastricht University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06455163 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials